欢迎使用我们的服务!
限时优惠,立即购买享受折扣
24小时客服在线,随时为您服务
优质产品,值得信赖
顶 置

How Oncologists Plan To Use Takeda/Protagonist’s Mimrylo For Polycythemia Vera

How Oncologists Plan To Use Takeda/Protagonist’s Mimrylo For Polycythemia Vera

Physicians have ideas about how rusfertide, which the FDA approved on Aug. 28, will be used in the clinic, though insurance coverage will remain a limitation.